Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SCLN $11.24 1.4200 +14.46%
ONTX $2.60 0.2300 +9.70%
SNSS $3.25 0.2400 +7.97%
ENZN $1.27 0.0700 +5.83%
CVM $0.69 0.0300 +4.55%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ATRA $45.33 -7.4300 -14.08%
MGNX $35.18 -2.7900 -7.35%
EXEL $3.49 -0.2700 -7.18%
ADXS $18.92 -1.4100 -6.94%
INFI $10.33 -0.6200 -5.66%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

HPV Vaccination Should be Aimed at Girls, Study Says

(L.A. Times/Booster Shots blog) Dec 20, 2011 - Vaccination against human papilloma virus was recommended for U.S. girls almost five years ago.
read article (free registration required) 

AstraZeneca Places Two New Bets After R&D Setbacks

(Reuters) Dec 21, 2011 - AstraZeneca is placing new bets on drug research by signing deals with two Asian companies, just one day after suffering a double setback for two of its most important pipeline assets.
read article 

At 25, Moffitt Remains Focused on Prevention, Treatment

(Tampa Bay Online) Dec 21, 2011 - The H. Lee Moffitt Cancer Center isn't like other hospitals. Its doctors, nurses and staff don't deliver babies or perform elective surgeries. They have one mission: to prevent and treat cancer.
read article 

Jennerex Announces First Patient Treated in Phase 2a Clinical Trial of JX-594 as a Neoadjuvant Therapy in Colorectal Cancer Patients Undergoing Surgery

(Yahoo! Finance) Dec 21, 2011 - Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 2a clinical trial of JX-594 as a neoadjuvant therapy in patients who are undergoing surgery to treat colorectal cancer that has spread to the liver.
read article 

Celldex Completes Accrual Of CDX-011 Phase 2b “EMERGE” Study In Advanced Breast Cancer

(The Street) Dec 21, 2011 - Celldex Therapeutics, Inc. today announced that it has completed accrual of the EMERGE study, a randomized Phase 2b study evaluating CDX-011 (glembatumumab vedotin) in patients with previously treated metastatic or locally advanced breast cancer.
read article 

Antigen Express Breast Cancer Vaccine Development

(Bloomberg/Video) Dec 20, 2011 - Bloomberg's Cali Carlin reports on Antigen Express Inc.'s efforts to develop a breast cancer vaccine. Bloomberg's Emily Chang also speaks on Bloomberg Television's "Bloomberg West."
read article 

Exelixis Licenses PI3K-Delta Program To Merck

(The Street) Dec 21, 2011 - Exelixis, Inc. today announced that it has granted to Merck, known as MSD outside of the United States and Canada, an exclusive worldwide license to its PI3K-delta research and development program, including XL499, the company’s most advanced preclinical PI3K-delta inhibitor and other related compounds.
read article 

Millennium: Takeda Acquires San Diego’s Intellikine for $190M Upfront

(Xconomy) Dec 20, 2011 - Japan-based Takeda Pharmaceuticals, which has its cancer drug development operations in Cambridge, MA, said today it is acquiring San Diego-based Intellikine to get ahold of the startup’s portfolio of cancer drugs in the pipeline.
read article 

Self-Regulation of the Immune System Suppresses Defense Against Cancer

(Helmholtz Association of German Research Centres) Dec 21, 2011 - Regulatory T cells (Tregs), which are part of the body’s immune system, downregulate the activity of other immune cells, thus preventing the development of autoimmune diseases or allergies.
read press release 

Positive Feedback and Tumorigenesis

(Ludwig-Maximilians-Universität München [Munich]) Dec 20, 2011 - Cancer cells are essentially immortal. The acquisition of an unlimited capacity to divide – the process of immortalization - is a central event in the genesis of tumors.
read article 

Study Reveals How Normal Cells Fuel Tumor Growth

(Ohio State University Comprehensive Cancer Center) Dec 21, 2011 - A new study published in the journal Nature Cell Biology has discovered how normal cells in tumors can fuel tumor growth.
read press release 

Pancreatic Cancer Linked to Minerals

(UPI) Dec 20, 2011 - People with high levels of the trace elements nickel and selenium may have a reduced risk of developing pancreatic cancer, U.S. and Spanish researchers say.
read article 

UF, Moffitt Researchers Find Blood Cancer May be More Common Than Realized

(University of Florida) Dec 20, 2011 - A group of life-threatening blood disorders collectively called myelodysplastic syndrome, or MDS, may occur four times more often than reported by national cancer registries, according to new research from the University of Florida based on data from Medicare claims.
read article 

Evolving Ovarian Cancer Cells 'Dodge' Treatment with Chemotherapy

(Cancer Research UK) Dec 19, 2011 - Cancer Research UK scientists have discovered that the commonest type of ovarian cancer evolves at a startling rate, which may allow cancer cells to ‘dodge’ the current standard treatment, reveals research in The Journal of Pathology today.
read press release 

Removal of Lymph Nodes During Surgery for Thyroid Cancer May be Beneficial

(UCLA Health System) Dec 20, 2011 - Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women. A new study indicates that routinely removing lymph nodes in the neck in these cancer patients may help prevent the disease from coming back.
read press release 

40 Years On, the Triumphs and Challenges of America's 'War on Cancer'

(U.S. News & World Report/HealthDay) Dec 21, 2011 - In many cases, what was a death sentence is now a manageable condition, although roadblocks remain.
read article 

Ruptured French Breast Implants May Prompt Drastic Move: Telling 30,000 Women to Remove Theirs

(Washington Post/AP) Dec 21, 2011 - Emmanuelle Maria’s breasts were burning and globules of silicone gel were protruding into her armpits. Her implants had exploded inside her. Yet her doctors, she says, told her nothing was wrong.
read article (free registration required) 

Bayer: Four Potential Blockbusters in the Pharma Pipeline

(Bayer) Dec 20, 2011 - Good prospects for Xarelto™, VEGF Trap-Eye, Alpharadin and regorafenib; market launches in the next 18 months planned; research and development budget for 2012 approximately EUR 3 billion again.
read corporate press release 

CMS Taps 32 Health Systems for Pioneer ACO Program

(Healthcare Finance News) Dec 20, 2011 - The Centers for Medicare & Medicaid Services announced yesterday the 32 health systems that will participate in the Pioneer Accountable Care Organization program, which government officials say could save Medicare as much as $1.1 billion.
read article 

Sanofi, Novartis, Astrazeneca Get Poor Results from Trial Tests on Key Drugs

(Washington Post/Associated Press) Dec 20, 2011 - Three top European pharmaceutical companies announced on Tuesday disappointing news from clinical tests on drugs they had hoped would turn out to be big sellers.
read article (free registration required) 

FDA Revises Sanofi Multaq Label on Heart Risks

(Reuters) Dec 20, 2011 - U.S. regulators on Monday revised the label for Sanofi SA's heart drug Multaq to reflect a doubling of health risks, including death, for some patients with irregular heart rhythms.
read article 

Can Patients Handle the Truth? Getting Access to Doctors’ Notes

(Time Healthland) Dec 20, 2011 - A new study asks patients if they want to read what their doctor is writing in their chart. Overwhelmingly, the answer was yes. Not surprisingly, doctors resist.
read article 

The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study

(Yahoo! Finance) Dec 19, 2011 - The Multiple Myeloma Research Foundation (MMRF) today announced that four leading cancer centers are enrolling patients as part of the landmark 1,000-patient study designed to characterize the genetic variation in multiple myeloma.
read article 

The Race is on for a Better Mammogram

(CNN Money) Dec 19, 2011 - When his first wife went into a coma following cardiac arrest in 1978, nuclear physicist Dr. Edward Flynn vowed to build a machine that could save lives.
read article 

When Terminally Ill Patients Ask How Long They Have, Doctors Find it Hard to Say

(Washington Post) Dec 19, 2011 - In January, when my close friend’s lymph node biopsy came back as a rare form of T-cell lymphoma, I scoured the scientific literature. What was his prognosis?
read article (free registration required)